Daniel W Muehl Clovis Oncology, Inc. (CLVS) insider trading activity

Daniel W Muehl is Officer of Clovis Oncology, Inc.. Currently has a direct ownership of 104,830 shares of CLVS, which is worth approximately $9,434. The most recent transaction as insider was on Nov 02, 2022, when has been sold 4,579 shares (Common Stock) at a price of $0.98 per share, resulting in proceeds of $4,487. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 105K

0% 3M change

0% 12M change

Total Value Held $9,434

DANIEL W MUEHL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 02 2022	SELL Open market or private sale	$4,487 $0.98 p/Share	4,579 Reduced 4.19%	104,830 Common Stock
Nov 01 2022	BUY Exercise of conversion of derivative security	-	10,248 Added 8.75%	106,896 Common Stock
Sep 02 2022	SELL Open market or private sale	$2,681 $1.2 p/Share	2,234 Reduced 2.2%	99,161 Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	-	5,063 Added 4.76%	101,395 Common Stock
Aug 02 2022	SELL Open market or private sale	$6,795 $1.46 p/Share	4,654 Reduced 4.61%	96,332 Common Stock
Aug 01 2022	BUY Exercise of conversion of derivative security	-	10,249 Added 9.43%	98,432 Common Stock
Jun 02 2022	SELL Open market or private sale	$1,489 $0.64 p/Share	2,327 Reduced 2.5%	90,737 Common Stock
Jun 01 2022	BUY Exercise of conversion of derivative security	-	5,062 Added 5.16%	93,064 Common Stock
May 02 2022	SELL Open market or private sale	$9,003 $1.97 p/Share	4,570 Reduced 4.94%	88,002 Common Stock
May 01 2022	BUY Exercise of conversion of derivative security	-	10,248 Added 10.22%	90,064 Common Stock
Mar 02 2022	SELL Open market or private sale	$20,020 $1.87 p/Share	10,706 Reduced 11.51%	82,324 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	-	20,813 Added 18.33%	92,740 Common Stock
Feb 02 2022	SELL Open market or private sale	$10,546 $1.94 p/Share	5,436 Reduced 7.0%	72,217 Common Stock
Feb 01 2022	BUY Exercise of conversion of derivative security	-	10,250 Added 12.07%	74,670 Common Stock
Dec 02 2021	SELL Open market or private sale	$744 $3.0 p/Share	248 Reduced 0.37%	67,403 Common Stock
Dec 01 2021	BUY Exercise of conversion of derivative security	-	562 Added 0.82%	67,651 Common Stock
Nov 02 2021	SELL Open market or private sale	$20,580 $4.55 p/Share	4,523 Reduced 6.32%	67,089 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	-	10,248 Added 12.91%	69,130 Common Stock
Sep 02 2021	SELL Open market or private sale	$1,218 $4.89 p/Share	249 Reduced 0.4%	61,364 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	-	563 Added 0.91%	61,613 Common Stock
Aug 03 2021	SELL Open market or private sale	$21,724 $4.82 p/Share	4,507 Reduced 6.87%	61,050 Common Stock
Aug 01 2021	BUY Exercise of conversion of derivative security	-	10,249 Added 13.98%	63,084 Common Stock
Jun 03 2021	SELL Open market or private sale	$1,301 $5.63 p/Share	231 Reduced 0.42%	55,308 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	-	562 Added 1.0%	55,539 Common Stock
May 04 2021	SELL Open market or private sale	$26,797 $5.54 p/Share	4,837 Reduced 8.09%	54,977 Common Stock

DWM

Daniel W Muehl

Officer

Boulder, CO

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLVS shares.

Notify only if

Value

Insider Trading

Get notified when an Clovis Oncology, Inc. insider buys or sells CLVS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Clovis Oncology, Inc.

Track Activities on CLVS

Account